0001179110-20-008585.txt : 20200730
0001179110-20-008585.hdr.sgml : 20200730
20200730190304
ACCESSION NUMBER: 0001179110-20-008585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200729
FILED AS OF DATE: 20200730
DATE AS OF CHANGE: 20200730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILMAN STEVEN C
CENTRAL INDEX KEY: 0001379970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 201061749
MAIL ADDRESS:
STREET 1: 110 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-07-29
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001379970
GILMAN STEVEN C
C/O MOMENTA PHARMACEUTICALS, INC
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2020-07-29
4
M
0
10000
10.63
A
17796
D
Common Stock
2020-07-29
4
S
0
10000
29.70
D
7796
D
Stock Option (Right to Buy)
10.63
2020-07-29
4
M
0
10000
0
D
2018-06-22
2026-06-22
Common Stock
10000
13000
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020
This transaction was executed in multiple trades at prices ranging from $29.20 to $30.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ R. Mark Chamberlin as attorney in fact
2020-07-30